Download Free Statistical Applications From Clinical Trials And Personalized Medicine To Finance And Business Analytics Book in PDF and EPUB Free Download. You can read online Statistical Applications From Clinical Trials And Personalized Medicine To Finance And Business Analytics and write the review.

The papers in this volume represent a broad, applied swath of advanced contributions to the 2015 ICSA/Graybill Applied Statistics Symposium of the International Chinese Statistical Association, held at Colorado State University in Fort Collins. The contributions cover topics that range from statistical applications in business and finance to applications in clinical trials and biomarker analysis. Each papers was peer-reviewed by at least two referees and also by an editor. The conference was attended by over 400 participants from academia, industry, and government agencies around the world, including from North America, Asia, and Europe.
Since the publication of the first edition in 2000, there has been an explosive growth of literature in biopharmaceutical research and development of new medicines. This encyclopedia (1) provides a comprehensive and unified presentation of designs and analyses used at different stages of the drug development process, (2) gives a well-balanced summary of current regulatory requirements, and (3) describes recently developed statistical methods in the pharmaceutical sciences. Features of the Fourth Edition: 1. 78 new and revised entries have been added for a total of 308 chapters and a fourth volume has been added to encompass the increased number of chapters. 2. Revised and updated entries reflect changes and recent developments in regulatory requirements for the drug review/approval process and statistical designs and methodologies. 3. Additional topics include multiple-stage adaptive trial design in clinical research, translational medicine, design and analysis of biosimilar drug development, big data analytics, and real world evidence for clinical research and development. 4. A table of contents organized by stages of biopharmaceutical development provides easy access to relevant topics. About the Editor: Shein-Chung Chow, Ph.D. is currently an Associate Director, Office of Biostatistics, U.S. Food and Drug Administration (FDA). Dr. Chow is an Adjunct Professor at Duke University School of Medicine, as well as Adjunct Professor at Duke-NUS, Singapore and North Carolina State University. Dr. Chow is the Editor-in-Chief of the Journal of Biopharmaceutical Statistics and the Chapman & Hall/CRC Biostatistics Book Series and the author of 28 books and over 300 methodology papers. He was elected Fellow of the American Statistical Association in 1995.
This book brings together the voices of leading experts in the frontiers of biostatistics, biomedicine, and the health sciences to discuss the statistical procedures, useful methods, and novel applications in biostatistics research. It also includes discussions of potential future directions of biomedicine and new statistical developments for health research, with the intent of stimulating research and fostering the interactions of scholars across health research related disciplines. Topics covered include: Health data analysis and applications to EHR data Clinical trials, FDR, and applications in health science Big network analytics and its applications in GWAS Survival analysis and functional data analysis Graphical modelling in genomic studies The book will be valuable to data scientists and statisticians who are working in biomedicine and health, other practitioners in the health sciences, and graduate students and researchers in biostatistics and health.
In this book readers will find technological discussions on the existing and emerging technologies across the different stages of the big data value chain. They will learn about legal aspects of big data, the social impact, and about education needs and requirements. And they will discover the business perspective and how big data technology can be exploited to deliver value within different sectors of the economy. The book is structured in four parts: Part I “The Big Data Opportunity” explores the value potential of big data with a particular focus on the European context. It also describes the legal, business and social dimensions that need to be addressed, and briefly introduces the European Commission’s BIG project. Part II “The Big Data Value Chain” details the complete big data lifecycle from a technical point of view, ranging from data acquisition, analysis, curation and storage, to data usage and exploitation. Next, Part III “Usage and Exploitation of Big Data” illustrates the value creation possibilities of big data applications in various sectors, including industry, healthcare, finance, energy, media and public services. Finally, Part IV “A Roadmap for Big Data Research” identifies and prioritizes the cross-sectorial requirements for big data research, and outlines the most urgent and challenging technological, economic, political and societal issues for big data in Europe. This compendium summarizes more than two years of work performed by a leading group of major European research centers and industries in the context of the BIG project. It brings together research findings, forecasts and estimates related to this challenging technological context that is becoming the major axis of the new digitally transformed business environment.
Comprehensive resource covering tools and techniques used for predictive analytics with practical applications across various industries Intelligent Techniques for Predictive Data Analytics provides an in-depth introduction of the tools and techniques used for predictive analytics, covering applications in cyber security, network security, data mining, and machine learning across various industries. Each chapter offers a brief introduction on the subject to make the text accessible regardless of background knowledge. Readers will gain a clear understanding of how to use data processing, classification, and analysis to support strategic decisions, such as optimizing marketing strategies and customer relationship management and recommendation systems, improving general business operations, and predicting occurrence of chronic diseases for better patient management. Traditional data analytics uses dashboards to illustrate trends and outliers, but with large data sets, this process is labor-intensive and time-consuming. This book provides everything readers need to save time by performing deep, efficient analysis without human bias and time constraints. A section on current challenges in the field is also included. Intelligent Techniques for Predictive Data Analytics covers sample topics such as: Models to choose from in predictive modeling, including classification, clustering, forecast, outlier, and time series models Price forecasting, quality optimization, and insect and disease plant and monitoring in agriculture Fraud detection and prevention, credit scoring, financial planning, and customer analytics Big data in smart grids, smart grid analytics, and predictive smart grid quality monitoring, maintenance, and load forecasting Management of uncertainty in predictive data analytics and probable future developments in the field Intelligent Techniques for Predictive Data Analytics is an essential resource on the subject for professionals and researchers working in data science or data management seeking to understand the different models of predictive analytics, along with graduate students studying data science courses and professionals and academics new to the field.
Artificial Intelligence (AI) in Healthcare is more than a comprehensive introduction to artificial intelligence as a tool in the generation and analysis of healthcare data. The book is split into two sections where the first section describes the current healthcare challenges and the rise of AI in this arena. The ten following chapters are written by specialists in each area, covering the whole healthcare ecosystem. First, the AI applications in drug design and drug development are presented followed by its applications in the field of cancer diagnostics, treatment and medical imaging. Subsequently, the application of AI in medical devices and surgery are covered as well as remote patient monitoring. Finally, the book dives into the topics of security, privacy, information sharing, health insurances and legal aspects of AI in healthcare. - Highlights different data techniques in healthcare data analysis, including machine learning and data mining - Illustrates different applications and challenges across the design, implementation and management of intelligent systems and healthcare data networks - Includes applications and case studies across all areas of AI in healthcare data
Contains information to understand the trends, technologies, finances, and leading companies of a specific industry.
By enabling the conversion of traditional manufacturing systems into contemporary digitalized ones, Internet of Things (IoT) adoption in manufacturing creates huge economic prospects through reshaping industries. Modern businesses can more readily implement new data-driven strategies and deal with the pressure of international competition thanks to Industrial IoT. But as the use of IoT grows, the amount of created data rises, turning industrial data into Industrial Big Data. Internet of Things and Big Data Analytics-Based Manufacturing shows how Industrial Big Data can be produced as a result of IoT usage in manufacturing, considering sensing systems and mobile devices. Different IoT applications that have been developed are demonstrated and it is shown how genuine industrial data can be produced, leading to Industrial Big Data. This book is organized into four sections discussing IoT and technology, the future of Big Data, algorithms, and case studies demonstrating the use of IoT and Big Data in a variety of industries, including automation, industrial manufacturing, and healthcare. This reference title brings all related technologies into a single source so that researchers, undergraduate and postgraduate students, academicians, and those in the industry can easily understand the topic and further their knowledge.
Data sharing can accelerate new discoveries by avoiding duplicative trials, stimulating new ideas for research, and enabling the maximal scientific knowledge and benefits to be gained from the efforts of clinical trial participants and investigators. At the same time, sharing clinical trial data presents risks, burdens, and challenges. These include the need to protect the privacy and honor the consent of clinical trial participants; safeguard the legitimate economic interests of sponsors; and guard against invalid secondary analyses, which could undermine trust in clinical trials or otherwise harm public health. Sharing Clinical Trial Data presents activities and strategies for the responsible sharing of clinical trial data. With the goal of increasing scientific knowledge to lead to better therapies for patients, this book identifies guiding principles and makes recommendations to maximize the benefits and minimize risks. This report offers guidance on the types of clinical trial data available at different points in the process, the points in the process at which each type of data should be shared, methods for sharing data, what groups should have access to data, and future knowledge and infrastructure needs. Responsible sharing of clinical trial data will allow other investigators to replicate published findings and carry out additional analyses, strengthen the evidence base for regulatory and clinical decisions, and increase the scientific knowledge gained from investments by the funders of clinical trials. The recommendations of Sharing Clinical Trial Data will be useful both now and well into the future as improved sharing of data leads to a stronger evidence base for treatment. This book will be of interest to stakeholders across the spectrum of research-from funders, to researchers, to journals, to physicians, and ultimately, to patients.